Bond.az White LogoBond.az Black Logo

BTIG Reiterates Neutral on Affirm Stock

BTIG reiterates Neutral on Affirm stock amid credit trends. Analysis of delinquencies, growth prospects, and analyst targets.

Zoe Allen
ByZoe Allen- Senior Editor
|
0

BTIG reiterated a Neutral stock rating on Affirm Holdings (NASDAQ: AFRM), citing mixed signals in the company's April trust data. The stock is currently trading at $65.22 with a market cap of $21.84 billion.

Early-stage delinquencies in the 30-59 day category declined month-over-month across all vintages. However, the 2025-X2 vintage shows elevated early-stage delinquency rates compared to historical norms, raising concerns.

BTIG noted that the higher delinquency rate may be intentional, as Affirm expects revenue less transaction costs (RLTC) margins to compress from above 4.0% due to higher loss expectations. This could allow Affirm to approve more loans and boost gross merchandise volume (GMV).

The strategy remains viable if RLTC margins stay within 3.75%-4.00% while GMV grows above 30% year-over-year. Affirm has demonstrated strong revenue growth of 32% over the last twelve months and turned profitable with diluted EPS of $1.06.

BTIG does not expect Affirm to loosen underwriting further to drive GMV growth, as this could push RLTC margins below guidance. The market should not expect significant beat-and-raise outcomes for GMV going forward.

In other news, Affirm integrated its BNPL options into Google Search and Gemini app via Google Pay. Compass Point raised its price target to $80, Mizuho to $100, Evercore ISI to $90, and Citizens to $85.

More News
Today / 11:03
|
631

Jefferies Raises SentinelOne Price Target to $24

Jefferies raised SentinelOne price target to $24 on margin outlook, maintaining Buy rating. Stock at $18.71, NNARR growth expected. Analyst sees H2 margin expansion.

0
Today / 11:02
|
566

ThinkEquity Initiates Atlas with Buy

ThinkEquity initiates Atlas Technical Consultants with a Buy rating and $15 target. The firm highlights the value of the Brazil critical-minerals option.

0
Today / 11:00
|
941

Reddit Stock Rating Boosted by App Growth

Citizens maintains Market Outperform on Reddit stock with $240 target. App installs surged 129% YoY, driving advertising growth.

0
Today / 10:33
|
492

Wolfe Research Reaffirms Ionis Stock Outperform Rating

Wolfe Research reiterates Outperform rating on Ionis Pharmaceuticals stock. Analysis of Arrowhead competition and financial results.

0
Today / 10:31
|
510

BTIG reiterates Uber Buy rating after Delivery Hero bid

BTIG reaffirms Uber Buy rating with $100 target after Delivery Hero bid. Stock seen as undervalued.

0
Today / 10:02
|
707

Mizuho Cuts Intuit Target on TurboTax Weakness

Mizuho cuts Intuit target to $500 on TurboTax weakness; shares fall 20%. Read more on Bond.az.

0
Today / 08:00
|
677

Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy

Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.

0
Today / 06:02
|
602

Goldman Sachs Initiates Hemab Buy

Goldman Sachs initiates Hemab Therapeutics with buy rating. Sutacimig and HMB-002 target rare bleeding disorders.

0
Today / 06:01
|
425

Morgan Stanley Initiates Avalyn Pharma with Overweight

Morgan Stanley initiates Avalyn Pharma with Overweight rating and $53 target. The inhaled therapies AP01 and AP02 show promise in pulmonary fibrosis.

0
Today / 06:00
|
496

Goldman Sachs Backs Seaport Stock

Goldman Sachs initiates coverage on Seaport Therapeutics with an Early-Stage Biotech rating. Learn about the company's platform and financials.

0
Yesterday / 15:32
|
644

Jefferies Initiates Avalyn Pharma with Buy

Jefferies initiates Avalyn Pharma with Buy rating and $52 price target. AP01 shows promising efficacy in progressive lung diseases.

0
Yesterday / 15:31
|
924

Jefferies Initiates Pershing Square USA Buy

Jefferies initiates Buy rating on Pershing Square USA (PSUS), highlighting the fund's strategy, discount, and lack of performance fee.

0
...
BTIG Reiterates Neutral on Affirm Stock | Bond.az